LEVOSIMENDAN TILLOMED 2.5mg / ml concentrate for solution for infusion medication leaflet

C01CX08 levosimendan • Cardiovascular system | Cardiac stimulants excluding cardiac glycosides | Other cardiac stimulants

Levosimendan is a medication used for the treatment of acute decompensated heart failure. It acts as a calcium sensitizer, improving myocardial contractility without increasing oxygen consumption.

The medication is administered intravenously, usually as an infusion, under the supervision of a specialist. The dose is adjusted based on the patient's response and tolerance.

Side effects may include low blood pressure, headaches, nausea, or cardiac arrhythmias. In rare cases, severe allergic reactions may occur.

Levosimendan is not recommended for patients with severe hypotension, severe renal or hepatic impairment, or hypersensitivity to this medication.

General data about LEVOSIMENDAN TILLOMED 2.5mg / ml

Substance: levosimendan

Date of last drug list: 01-05-2025

Commercial code: W70185001

Concentration: 2.5mg / ml

Pharmaceutical form: concentrate for solution for infusion

Quantity: 1

Product type: generic

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: MIAS PHARMA LIMITED - IRLANDA

Holder: PHARMA S.A. - ROMANIA

Number: 888/2024/01

Shelf life: 2 years-unopened bottle

Other substances similar to levosimendan